132 related articles for article (PubMed ID: 36066130)
1. Primary Cutaneous Anaplastic Large-Cell Lymphoma With Aberrant CD20 Expression: Case Report and Review of the Literature.
Mark E; Sutton M; Gru A
Am J Dermatopathol; 2022 Dec; 44(12):971-978. PubMed ID: 36066130
[TBL] [Abstract][Full Text] [Related]
2. Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.
Karimkhani C; McLaughlin C; Smith C
J Drugs Dermatol; 2015 May; 14(5):515-6. PubMed ID: 25942672
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous CD20-positive T-cell lymphoma.
Martin B; Stefanato C; Whittaker S; Robson A
J Cutan Pathol; 2011 Aug; 38(8):663-9. PubMed ID: 21623866
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of CD20
Ewing TS; Pieper JB; Stern AW
Vet Dermatol; 2019 Feb; 30(1):51-e14. PubMed ID: 30474245
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous Gamma-Delta T-Cell Lymphoma Mimicking anaplastic lymphoma kinase-1-Negative Anaplastic Large Cell Lymphoma: A Case Report.
Meawad H; Song JY; Ulrickson ML; Weisenburger DD
Am J Dermatopathol; 2022 Jan; 44(1):62-65. PubMed ID: 34889814
[TBL] [Abstract][Full Text] [Related]
6. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
[TBL] [Abstract][Full Text] [Related]
7. Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder: A Case Report.
Salva KA; Bennett D; Longley J; Guitart J; Wood GS
Am J Dermatopathol; 2015 Oct; 37(10):e116-21. PubMed ID: 26381030
[TBL] [Abstract][Full Text] [Related]
8. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
[TBL] [Abstract][Full Text] [Related]
9. Variable loss of CD30 expression by immunohistochemistry in recurrent cutaneous CD30+ lymphoid neoplasms treated with brentuximab vedotin.
Goyal A; Patel S; Goyal K; Morgan EA; Foreman RK
J Cutan Pathol; 2019 Nov; 46(11):823-829. PubMed ID: 31286556
[TBL] [Abstract][Full Text] [Related]
10. CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides).
Brachelente C; Affolter VK; Fondati A; Porcellato I; Sforna M; Lepri E; Mechelli L; Bongiovanni L
Vet Pathol; 2016 May; 53(3):563-6. PubMed ID: 26354309
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy.
Clarke LE; Bayerl MG; Ehmann WC; Helm KF
J Cutan Pathol; 2003 Aug; 30(7):459-62. PubMed ID: 12859745
[TBL] [Abstract][Full Text] [Related]
12. CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review.
Kakinoki Y; Hashiguchi J; Ishio T; Chiba K; Niino D; Ohshima K
Int J Hematol; 2015 Dec; 102(6):702-8. PubMed ID: 26251099
[TBL] [Abstract][Full Text] [Related]
13. CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature.
Alvaro-Naranjo T; Jaén-Martínez J; Gumá-Padró J; Bosch-Príncep R; Salvadó-Usach MT
Ann Hematol; 2003 Sep; 82(9):585-8. PubMed ID: 12898184
[TBL] [Abstract][Full Text] [Related]
14. Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20.
Frings VG; Roth S; Riedmiller AL; Schäfer K; Goebeler M; Rosenwald A; Geissinger E; Wobser M
Acta Derm Venereol; 2017 Apr; 97(4):534-536. PubMed ID: 27840885
[No Abstract] [Full Text] [Related]
15. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous anaplastic large cell lymphoma simulating an aggressive angiocentric T-cell lymphoma.
Fuertes I; Mascaró JM; Martínez A; García-Herrera A; Estrach TE
Int J Dermatol; 2013 Oct; 52(10):1241-4. PubMed ID: 22458926
[No Abstract] [Full Text] [Related]
17. Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy.
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Cancer Sci; 2009 Jan; 100(1):54-61. PubMed ID: 19038008
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
Bonnekoh B; Schulz M; Franke I; Gollnick H
J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
Liu YA; Finn AJ; Subtil A
J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
